Cannabis Stocks Experience Uptick Amid Optimism
Cannabis stocks, particularly Tilray (NASDAQ: TLRY), saw a rise of 3.2% in the morning trading session. This boost in the cannabis sector came as a result of growing optimism for U.S. cannabis reform, bolstered by encouraging insights from analysts at Jefferies.
The positive vibes stem from reports suggesting that the Trump administration might consider reclassifying marijuana from its current Schedule I designation to the more lenient Schedule III. If this change happens, it could remove some significant barriers related to banking, taxation, and operations for cannabis companies.
After an initial spike, Tilray’s shares cooled down to $1.42, marking a modest increase of 0.7% from the prior close.
Investors might be wondering if it’s a good time to grab some Tilray stocks. The inquiry arises especially in light of the stock’s history—Tilray has seen a staggering 66 movements over 5% just last year. So, while today’s uptick reflects the market’s reception of the news, it doesn’t fundamentally alter the business’s perception.
Notably, just yesterday, we noted a significant increase of 18.6% after Jefferies raised its price target for Tilray, ignited by the rising optimism regarding potential changes in federal cannabis policy. Jefferies has set Tilray’s new target at $2.50, up from $1.50, while maintaining a buy rating, largely due to the chance of cannabis being reclassified from Schedule I to Schedule III.
This rising optimism follows President Trump’s remarks about reassessing how cannabis is classified. While full legalization is not on the table, such a rescheduling would signify a significant shift in federal policy. For many cannabis companies, this could translate into substantial advantages—lowering tax liabilities and enabling research opportunities. Jefferies highlighted Tilray as a likely “large potential beneficiary” of these regulatory changes. The overall positive sentiment has also revived hopes for safety banking laws that would elevate cannabis stocks and provide these companies access to traditional banking services.
Since the beginning of the year, Tilray has dipped 3.1%, currently sitting at $1.42 per share, which is about 23.9% lower than its 52-week high of $1.86 reached in August 2024.
It’s interesting to consider that younger investors today might not be reflecting on timeless lessons from past market movements, like those captured in “gorilla games.” This concept originated over two decades ago, marking the reign of Microsoft and Apple. However, applying those same principles today, enterprise software leveraging generative AI could be the next big winner. With that in mind, we’re eager to share a special free report on profitable, rapidly growing enterprise software stocks that are already riding the automation wave and looking to latch onto generative AI developments.
